Veterinary Endoscopes Market is estimated to Grow Significantly with 6.7% of CAGR by 2027

PUNE, MAHARASTRA, INDIA, November 28, 2019 /EINPresswire.com/ — According to a new market research study titled 'Veterinary Endoscopes Market to 2027 – Global Analysis and Forecasts by Product Type, Application, Procedure, End User and Geography'. The global veterinary endoscopes market is expected to reach US$ 478.84 Mn in 2027 from US$ 268.82 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. The report highlights the trends prevalent in the global veterinary endoscopes market and the factors driving the market along with those that act as challenges to its growth.

Global the veterinary endoscopes market is segmented on the basis of product type, application, procedures and end user. The market based on product type segment is classified as capsule endoscopes, flexible endoscopes and rigid endoscopes. On the basis application the market is segmented as diagnostic and surgical. Based on the procedure the market is classified as bronchoscopy, cystoscopy, gastrointestinal, laparoscopy, otoscopy, and other procedure types. And on the basis of end user the market is divided into veterinary clinic, veterinary hospitals and other end users.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00004198

The market for veterinary endoscopes is expected to grow significantly due to factors such increasing pet animal’s population, growing training programs for endoscopic diagnosis and rising incidences of zoonotic diseases over the forecasted years. Also, the growth opportunities in the developing nations are likely to have a positive impact on the growth of the market in the coming years

Global Veterinary Endoscopes Market – By Product Type

– Capsule Endoscopes
– Flexible Endoscopes
– Rigid Endoscopes

Global Veterinary Endoscopes Market – By Application

– Diagnostic
– Surgical

Global Veterinary Endoscopes Market – By Procedure

– Bronchoscopy
– Cystoscopy
– Gastrointestinal
– Laparoscopy
– Otoscopy
– Other Procedure Types

Global Veterinary Endoscopes Market – By End User

– Veterinary Clinic,
– Veterinary Hospitals
– Other End Users

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00004198

Sameer Joshi
The Insight Partners
+91 9666111581
email us here


Source: EIN Presswire

Teeth Whitening Market Anticipated to reach US$ 8,408.70 Mn in 2027 – Brodie & Stone, Procter & Gamble, Unilever

Teeth Whitening Market

Teeth Whitening Market expected to reach US$ 8,408.70 Mn in 2027 from US$ 5,857.61 Mn in 2018 with a CAGR of 4.2% from 2019-2027.

PUNE, INDIA, November 28, 2019 /EINPresswire.com/ — According to a new market research study of ‘Teeth whitening to 2027 – Global Analysis and Forecasts by Product, and Distribution Channel.’ The global teeth whitening market is anticipated to reach US$ 8,408.70 Mn in 2027 from US$ 5,857.61 Mn in 2018. The market is anticipated to grow with a CAGR of 4.2% from 2019-2027. The report provides the trends prevailing in the global teeth whitening market and the factors driving the market along with those that act as hindrances.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00007515/?EHM

There are various teeth whitening products like whitening toothpaste, whitening gels, whitening mouthwashes, strips, and other products obtained from a dentist. Peroxide is the main active ingredient in the whitening products offered by dentists in their clinics. The over-the-counter whitening products contain peroxide, which is effective and delivers good results if used as per directed. Thus people prefer home-based teeth whitening products as these are cost-effective and offer good results. The professional in-office whitening treatments may cost around US$300 – US$1,000 for a procedure which gives about 5-8 shades whiter teeth. Home teeth whitening products may cost around US$139- US$199, which may also give about 5-8 shades whiter teeth at home. In addition, as per the 2017 survey report by the American Academy of Cosmetic Dentistry (AACD), the average number of whitening procedures conducted in dental clinics in 2015 was 109, and the number reduced to 60.7 in 2017. The main reason for the decline in the professional in-office whitening treatments is the growing popularity of home-based whitening solutions.

Furthermore, many companies are providing customized, home-based solutions. For instance, Smile brilliant offers customized whitening trays which can be purchased online. When the customer receives the customized tray, the person will take their dental impressions and mail back to the company. In 1-2 weeks, the custom trays will be delivered to the customer and will be ready to use for teeth whitening treatment.

Thus such customized home-based solutions offered by the companies and the cost-effectiveness of the home-based solutions have led to increased adoption of home teeth whitening kits, which thereby propels the market growth.

Ask For Discount at https://www.theinsightpartners.com/discount/TIPRE00007515/?EHM

Moreover, in December 2018, GlaxoSmithKline plc signed agreement with Pfizer Inc to combine their consumer health businesses. The Joint Venture will be a category leader in pain relief, respiratory, vitamin and mineral supplements, digestive health, skin health and therapeutic oral health. Thus, partnerships, mergers, acquisitions and collaborations are expected to propel the growth of teeth whitening market over the forecast years.

The global teeth whitening market, based on product, was segmented as whitening toothpaste, whitening gels and strips, white light teeth whitening device, and other products. In 2018, the whitening toothpaste segment held the largest market share of the teeth whitening market by product. This segment is also projected to dominate the market in 2027 as toothpastes are easily accessible and are less expensive as compared to other teeth whitening products. This market segment is also expected to grow at a significant rate in the forecast period 2019 to 2027.

The leading companies operating in the teeth whitening market include Brodie & Stone, Johnson & Johnson Services, Inc., Colgate-Palmolive Company, Procter & Gamble (P&G), Unilever, GlaxoSmithKline plc, CCA Industries, Inc., Supersmile, Henkel, and Church & Dwight Co., Inc., among others. The market has observed different organic and inorganic advancements during recent years in the teeth whitening market. For instance, in March 2018, Unilever had signed an agreement to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in India, Bangladesh, and 20 other predominantly Asian markets. The merger involves the operations within GSK CH India, including a consignment selling agreement to distribute GSK’s Over-the-Counter and Oral Health products in India.

Table of Content:

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Teeth Whitening Market – By Product
1.3.2 Global Teeth Whitening Market – By Distribution Channel
1.3.3 Global Teeth Whitening Market – By Geography

2. Teeth Whitening Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Teeth Whitening– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Teeth Whitening Market in North America: PEST Analysis
4.2.2 Teeth Whitening Market in Europe: PEST Analysis
4.2.3 Teeth Whitening Market in Asia Pacific: PEST Analysis
4.2.4 Teeth Whitening Market in MEA: PEST Analysis
4.2.5 Teeth Whitening Market – South and Central America PEST Analysis
4.3 Expert Opinion

5. Global Teeth Whitening Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Awareness For Oral Hygiene
5.1.2 Increased Adoption of Home Teeth Whitening Kits
5.1.3 Technological Advancements in Teeth Whitening Products
5.2 Key Market Restraints
5.2.1 Side Effects Associated With Teeth Whitening
5.3 Key Market opportunity
5.3.1 Increasing Online Purchasing
5.4 Future Trend
5.4.1 The Boom in Cosmetic Dentistry
5.5 Impact Analysis

Continue….

Purchase this Premium Report at https://www.theinsightpartners.com/buy/TIPRE00007515/?EHM

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Sameer Joshi
The Insight Partners
+91 9666111581
email us here


Source: EIN Presswire

Antidiarrheal Drug Market Major Competitor Analysis – GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark

TheBusinessResearchCompany.com offers Antidiarrhoeals Drugs Global Market Report 2019 from its research database.

The global antidiarrhoeals market was valued at about $0.24 billion in 2018 and is expected to grow to $0.27 billion at a CAGR of 2.7% through 2022.”

— Abdul Wasay

LONDON, GREATER LONDON, UK, November 28, 2019 /EINPresswire.com/ — The global antidiarrheals market is expected to grow to $0.27 billion at a rate of about 2.7% through 2022. Rise in the number of diarrhea cases significantly contributes to the growth of antidiarrheal drugs market. According to UNICEF, as of 2016, diarrhea was the second leading cause of death among children under the age of 5 years that is responsible for killing 760,000 children every year. Increasing number of diarrheal cases increases the demand for antidiarrheal drugs. Increase in the use of biologics medicines poses to be a restraint to the antidiarrheal market.

The antidiarrheal drugs market consists of sale of antidiarrheal drugs and related services. Diarrhea is a disease affecting digestive parts of the body such as stomach, large intestine and rectum, esophagus, liver, gallbladder and pancreas and causes loose, watery bowel movements. Loperamide and bismuth subsalicylate are some examples of antidiarrheal drugs.

Request For A Free Sample For The Global Antidiarrheals Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2464&type=smp

The global antidiarrheals drugs market is further segmented based on type and geography.

By Type – The antidiarrheals drugs market is segmented by drug class into mucosal protectants and motility modifying drugs.

By Geography – The global antidiarrheals drugs is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Trends In The Antidiarrheals Drugs Market
Major companies in the antidiarrheal drug market are merging with other companies in the market to increase their reach and market share. Companies merge with or acquire other companies to expand their market share, diversify their product portfolio, or acquire new technologies.

Potential Opportunities In The Antidiarrheals Drugs Market
With growing population worldwide and increasing academia-industry collaborations to develop new drugs for treatment, the scope and potential for the global antidiarrheals drugs market is expected to significantly rise in the forecast period.

Major players in the market are GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals.
Antidiarrheals Drugs Global Market Report 2019 is one of a series of new reports from The Business Research Company that provides antidiarrheals drugs market overviews, analyzes and forecasts antidiarrheals drugs market size and growth for the global antidiarrheals drugs market, antidiarrheals drugs market share, antidiarrheals drugs market players, antidiarrheals drugs market size, antidiarrheals drugs market segments and geographies, antidiarrheals drugs market trends, antidiarrheals drugs market drivers and antidiarrheals drugs market restraints, antidiarrheals drugs market’s leading competitors’ revenues, profiles and market shares. The antidiarrheals drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More

Read Antidiarrheals Drugs Global Market Report 2019 from The Business Research Company for information on the following:

Markets Covered: global antidiarrheals drugs market

Data Segmentations: antidiarrheals drugs market size, global and by country; historic and forecast size, and growth rates for the world, 7 regions and 12 countries

Antidiarrheals Drugs Market Organizations Covered: GlaxoSmithKline, Actelion, Perrigo, Lupin and Glenmark Pharmaceuticals

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Time Series: Five years historic (2014-18) and forecast (2018-22).

Other Information And Analyses: PESTEL analysis, antidiarrheals drugs market customer information, antidiarrheals drugs market product/service analysis – product examples, antidiarrheals drugs market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global antidiarrheals drugs market in 2019 – countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Antidiarrheals Drugs Industry: the report explains a number of strategies for companies in the antidiarrheals drugs market, based on industry trends and company analysis.

Opportunities For Companies In The Antidiarrheals Drugs Sector: The report reveals where the global antidiarrheals drugs industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company?
The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Antidiarrheals Drugs Global Market Report 2019:

Gastrointestinal Drugs Global Market Report 2019 @ https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report

Metabolic Disorders Drugs Global Market Report 2019 @ https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) – Global Forecast To 2022

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

IoT in Healthcare Market Expected to Grow at a CAGR of 21.2% During the Forecast Period to 2025

PUNE, MAHARASHTRA, INDIA, November 28, 2019 /EINPresswire.com/ — According to the new research report published by The Insight Partners, titled “IoT in Healthcare – Global Analysis and Forecast to 2025”, the global IoT in healthcare market is expected to reach US$ 135.9 Bn in 2025, registering a CAGR of 21.2% during the forecast period 2017-2025.

In 2025, North America is expected to account for more than one-third of total IoT in healthcare revenue market share. The growth is majorly driven by enhanced IoT infrastructure in the region with better connectivity, availability of skilled professionals and rising incidences of chronic diseases such as obesity, diabetes etc.

Get Sample PDF Of Report@ https://www.theinsightpartners.com/sample/TIPTE100000180/

The IoT in Healthcare market is experiencing a high growth and adoption rate from past few years and is also expected to experience a significant growth and adoption rate in years to come. One of the major reason for high adoption of IoT in Healthcare is the need to decrease costs related to healthcare facilities worldwide. Developing economies with high growth in population and decreasing prices for internet services are providing opportunities for the players operating in the global IoT in Healthcare market. Few of the player that are operating successfully in global IoT in Healthcare market are Koninklijke Philips N.V., GE Healthcare, IBM Corp., Microsoft Corporation and others. Few of the factors that might act as a hindrance in the growth of the IoT in Healthcare market are high costs associated to smart devices and IoT infrastructure, and security and privacy concerns related to theft of highly confidential and sensitive health data of the patients.

Technology up gradation, government initiatives to deploy IoT solutions in healthcare industry, rising incidences of chronic diseases, and continuously increasing adoption of smart devices are some of the key driving factors for this market. Many healthcare institutions and providers are adopting IoT in healthcare solutions to deliver better care to their patients and optimize their clinical workflow. The global IoT in Healthcare market is broadly classified into solution (medical systems & devices and software solutions & tools), services (professional services & integration services) application (medication management, patient monitoring, fitness & wellness measurement, clinical workflow management and others) and end-user (patients & individuals, diagnostic & research and labs, hospitals & healthcare institutes and government authority); and geography.

Some Of Major Key Players In IoT in Healthcare Market:-

Koninklijke Philips N.V.,Medtronic Plc, Siemen Healthcare GmbH, Proteus Digital Health, Inc., IBM Watson Health, General Electric Healthcare, Microsoft Corporation, Qualcomm Life, Inc., STANLEY Healthcare, Verily Life Sciences LLC (Alphabet-Google)

Strategic Insights:

Market initiative was observed as the most adopted strategy in global IoT in Healthcare market. Few of the recent strategies by some of the players in IoT in Healthcare market landscape are listed below-

2016: The Office of the National Coordinator for IT (ONC) released Interoperability Standards Advisory (ISA) for the year 2017. This will enable patients’ to easily access their health data. This is an update to the ISA released in 2016.

2016: European Institute of Innovation and Technology for Health (EIT Health) funded a new research project in which Florida Atlantic University, Siemens Healthcare GmbH, Universitätsklinikum Erlangen along with other European partners will work together to develop a hybrid device for quicker diagnosis and treatment of strokes.

2016: IBM Watson Health partnered with Finnish Funding Agency for Innovation with an aim to enable Finland to utilize Watson cognitive computing to facilitate doctors enhance the health of Finland’s citizens, and support and develop the Finnish innovation and business ecosystem in the fields of health and well-being.

Wearable healthcare devices to boost the IoT in Healthcare market:-

IoT has a significant role to play in monitoring the health and safety of individual. Numerous pioneering wearable technologies have been developed in recent years that intent to revolutionize healthcare industry. Integration of IoT and wearable devices such as smart watch or health bands help to empower and educate patients to take control of their health and in turn boost the growth of IoT in Healthcare market. Some wearable devices also send data related to functioning of organs and disease markers to the physicians and helping in monitoring and diagnosing disease. Other wearable or portable health monitoring devices such as blood glucose level monitor helps diabetes patients in monitoring blood glucose levels, track food intake and deliver insulin and transmit the related data to their physicians. The number of health benefits of wearable devices and integration of IoT is further expected to result in reducing the overall treatment time and ease doctor patient interactions. Hence, wearable healthcare devices are expected to fuel the growth of IoT in Healthcare market in the coming years.

Adoption of connected medical devices fuelling the growth of IoT in Healthcare market:-

The adoption of IoT in Healthcare solution is witnessing a high growth and increasing need for integration and connectivity tools in escalating operations of healthcare organizations are the factors driving the growth of IoT in Healthcare market. The constantly decreasing costs of sensors embedded in these devices have resulted in falling prices of connected devices and hence, the adoption of connected medical devices have further increased. These devices connected to the internet and enable the healthcare professionals to get real-time information regarding patients’ health and helps in efficient monitoring. Furthermore, these devices send alerts to the nearby hospital in case of any emergency. Also, connected medical devices save lengthy communicating process between patients and healthcare providers. The valuable data recorded in the cloud through these devices helps in better diagnosis and analysis thereby, improving patients’ care. This trend is expected to further increase the growth of IoT in Healthcare market.

Buy This Research Report@ https://www.theinsightpartners.com/buy/TIPTE100000180/

Sameer Joshi
The Insight Partners
+1 646-491-9876
email us here


Source: EIN Presswire

Sanger Sequencing Service Market is Growing with $1,360.47 Million by 2027 and 12.2% of CAGR

Sanger sequencing is mainly recognized for DNA sequencing and supports applications in RNA sequencing and epigenetic analysis.

PUNE, MAHARASTRA, INDIA, November 27, 2019 /EINPresswire.com/ — Sanger sequencing is the superior method for sequencing, and it is a process of incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication. Sanger sequencing is known to provide high accuracy, long-read capabilities, and adaptability to support a diverse range of applications in many research areas.

Many of the evolving biotechnology and genetics start-ups are using DNA sequencing technologies for various applications. These new emerging companies are offering sequencing services that analyze human and animal genomes. For instance, located in Baltimore, United States, Personal Genome Diagnostics Inc. was founded in 2010 and is involved in genome analysis of human tumors. The company develops a patient-specific analysis of cancer by using sequencing tools and technologies.

Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00007514

According to a new market research study titled ‘Sanger Sequencing Service Market to 2027 – Global Analysis and Forecasts by Application, End User, and Geography.’ The global Sanger sequencing service market is expected to reach US$ 1,360.47 Mn in 2027 from US$ 489.43 Mn in 2018. The market is forecasted to grow with a CAGR of 12.2% during 2019-2027. The report highlights the trends prevalent in the global Sanger sequencing service market and the factors driving the market along with those that act as deterrents to its growth.

Global Sanger Sequencing Service Market – By Application

– Diagnostics
– Biomarkers and Cancer
– Reproductive Health
– Personalized Medicine
– Forensics
– Other Applications

Global Sanger Sequencing Service Market – By End User

– Academic and Government Research Institutes
– Biotechnology Companies and Pharmaceutical Companies
– Hospitals and Clinics
– Other End Users

The global Sanger sequencing service market, based on application, was segmented as, diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and other applications. In 2018 biomarkers and cancer held the largest share of the market, by application, due to the rising incidence of cancer, increasing the use of cancer biomarkers in drug discovery and diagnostics, and increasing research on cancer biomarkers.

The market for Sanger sequencing service is expected to grow owing to factors such as increasing providers for Sanger sequencing services and growing applications of Sanger sequencing. Also, an increase in the number of startup companies for genome analysis is expected to have a positive impact on the growth of the market in the coming years.

Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00007514

Sameer Joshi
The Insight Partners
+1 646-491-9876
email us here


Source: EIN Presswire

2nd Annual Chemo Buddies for Life GivingTuesday 36 Hour Streaming Live Event!

Tamara L. Hunter is Hosting the 501c3 Nonprofit, Chemo Buddies for Life's Streaming Live Event for 36 Hours to Raise Funds and See No One Faces Cancer Alone.

WINCHESTER, CA, UNITED STATES, November 27, 2019 /EINPresswire.com/ — On Monday, December 2, 2019 12:00 pm PST – 3:00 pm EST and continuing straight through to Tuesday, December 3, 2019 to midnight PST – 3:00 am EST, Tamara L. Hunter will host 36 hours of programming throughout multiple social media platforms and the Chemo Buddies for Life two websites www.chemobuddies4life.org and www.CB4L.org. There will be 36 unique hours of entertainment, inspiration and education designed to do two things; raise funds and enroll “buddies.”

Tamara L. Hunter co-founded the nonprofit two years ago and is on a global mission to end isolation, fear and depression associated with cancer. Chemo Buddies for Life is, “Healing Through Connections” within a community called “The Buddies Network.” Dedicated to those with all cancers, all stages this nonprofit supports the patient and also those who love and support them. “Our stand is it doesn’t matter what treatment anyone chooses, be it traditional, alternative, adjunctive; if someone hears those three words, the next thing they should do is get their own, “Buddy for Life!”

After winning the crown as the “First Global Next Impactor” on August 30, 2019 in Chicago, Tamara L. Hunter with the assistance of her coaches has created teams of purpose driven volunteers to take Chemo Buddies for Life to all areas of the world to make sure no one faces cancer alone.

Tamara L. Hunter is hosting the global event from Southern California. Monday and GivingTuesday there will be remote fundraisers taking place in multiple locations. From the PunkAssPiercings Ink in Toronto, Canada by Misty Blue and Carol Brown. To the Sunrise Pavilion at Siesta Key Public Beach in Sarasota, Florida by Stephen Smith. From the Silver Dance Ranch in Moroni, Utah by the “Oracle” Ruth V. Mellor and Erin Houchin. To the Angel’s Comedy Club in Chicago by “Patman and friends.” And, as far as Melbourne, Victoria, Australia by Vicky Omifolaji.

Scheduled each hour are performers, subject matter experts, inspiring stories and information regarding Chemo Buddies for Life. To donate or sign up to become a buddy today go to www.CB4L.org

About GivingTuesday:

GivingTuesday is a global generosity movement unleashing the power of people and organizations to transform their communities and the world on December 3, 2019 and every day. It was created in 2012 as a simple idea: a day that encourages people to do good. Once of the best ways to get involved with your community.

Contact Information:

Tamara L. Hunter (833) 922-1669
Chemo Buddies for Life
tlhunter@CB4L.org
www.CB4L.org
www.chemobuddies4life.org

DISTRIBUTION: SM & US Affiliates

Tamara L. Hunter
Chemo Buddies for Life
+1 833-922-1669
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Call to action: Stand Up for Human Rights and Defend the Rights of Human Trafficking Victims Nationwide in Annual March

This upcoming Sunday, December 8th, 2019, at 1 pm Youth for Human Rights DC Chapter will lead a march in honor of the 71st Anniversary of the United Nations Universal Declaration of Human Rights

This upcoming Sunday, December 8th, 2019, at 1 pm Youth for Human Rights DC Chapter will lead a march in honor of the 71st Anniversary of the United Nations Universal Declaration of Human Rights

The march will begin at the Lincoln Memorial and end at the World War II Memorial. Attendees are being encouraged to wear something blue in support of the United Nations Universal Declaration of Human Rights (UDHR).

The march will begin at the Lincoln Memorial and end at the World War II Memorial. Attendees are being encouraged to wear something blue in support of the United Nations Universal Declaration of Human Rights (UDHR).

Like-minded organization are encouraged to join in the march and can register or send inquiries by emailing: nationaloffice@humanrights.com

Like-minded organization are encouraged to join in the march and can register or send inquiries by emailing: nationaloffice@humanrights.com

Youth of all ages are encouraged to attend the march!

Youth of all ages are encouraged to attend the march!

Youth for Human Rights International and advocates organize march to raise awareness for human rights violations like human trafficking happening around the US.

We will march as a community to raise awareness of human rights and to bring hope at the idea of a brighter future where human rights will be respected by all.”

— Erica Rodgers, Director of the National Office of Youth for Human Rights

WASHINGTON, DC, USA, November 27, 2019 /EINPresswire.com/ — It is estimated that there are 40.3 million victims of human trafficking globally. Many of these victims are children within the United States. In a nation where such fundamental human rights are being abused, a group of human rights advocates have decided to gather together to stand up for human rights. On Sunday, December 8th, 2019, at 1 pm, the Youth for Human Rights DC Chapter will lead a march to stand up for the rights of children and victims of human trafficking around the country. The march will also be done in honor of the 71st Anniversary of the United Nations Universal Declaration of Human Rights.

The march begins at the iconic Lincoln Memorial and ends at the World War II Memorial. Attendees are being encouraged to wear something blue in support of the United Nations Universal Declaration of Human Rights (UDHR). Like-minded organizations are encouraged to join in the DC march and can register to participate in the #StandUp4HumanRightsMarch by going to: BIT.LY/HUMANRIGHTSMARCH2019

Erica Rodgers, the Director of the National Office of Youth for Human Rights and organizer of the march said, “We will march as a community to raise awareness of human rights and to bring hope at the idea of a brighter future where human rights will be respected by all.”

The United Nations launched their human rights awareness campaign under the banner of #StandUp4HumanRights in December of 2016. Over the past five years, Youth for Human Rights DC’s annual march has continued to support that same theme.

Adopted 71 years ago on December 10, 1948, the Universal Declaration of Human Rights was compiled as a result of the egregious human rights abuses perpetrated during the Second World War. With the end of that war, and the creation of the United Nations, the international community vowed never to allow atrocities of that kind to ever happen again.

The Youth for Human Rights DC march is part of a global series of events happening in many cities across the US as well as countries around the world in celebration of Human Rights Day 2019. To learn about similar marches happening near you email activities@humanrights.com.

About Youth for Human Rights:

Youth for Human Rights International (YHRI) is a nonprofit organization founded in 2001 whose mission is to teach youth about human rights, specifically the United Nations Universal Declaration of Human Rights (UDHR), and inspire them to become valuable advocates for respect and peace. YHRI teaches human rights education both in the classroom and in nontraditional educational settings such as through art series, concerts and other interactive community events. Their most recent campaign has included #KnowYour30 with the deliberate purpose of increasing awareness of the Universal Declaration of Human Rights list of the 30 human rights every person has – and how these become interwoven into everyday life. To learn more go to https://www.youthforhumanrights.org or watch
https://www.scientology.tv/series/voices-for-humanity/travis-ellis.html

Press Office
Youth for Human Rights International – National Office
+1 202-667-6404
email us here


Source: EIN Presswire

Do small testicles mean big health problems? – Dr. David Samadi

Dr. David Samadi

Testicles come in all shapes and sizes. But some men may worry about their size – are they too large or maybe too small?

NEW YORK, NEW YORK, USA, November 27, 2019 /EINPresswire.com/ — Do small testicles mean big health problems?

Just to be clear, generally speaking, small testicles are usually not a big health problem. Testicles come in all shapes and sizes. Whether lopsided or symmetrical, they’re all unique. But some men may worry about their size – are they too large or maybe too small? One way to assess testicle size is to measure the length from top to bottom. On average, this length is between 4.5 to 5.1 centimeters.

“Men with smaller-than-average testicles often worry if they are normal while men with normal to large testicles tend to have fewer concerns,” stated Dr. David Samadi, Director of Men’s Health at St. Francis Hospital in Roslyn, New York. “From my experience as a urologist, small testicles generally present few problems. However, if they have become smaller than normal over time, then it wouldn’t hurt to ask your doctor why this may be”

Here’s a look at potential causes of small testicles and how to treat it.

Low testosterone
It has been found that men who notice their testicles have shrunk could indicate low testosterone.
“While it is true that some men with low testosterone may notice a smaller size of their testicles, it’s not true for all men,” explained Dr. Samadi. “You have to look at the entire picture of a man and what other symptoms he may be experiencing.”

Other symptoms of low testosterone besides small testicles can include:
A low sex drive
Difficulty achieving and maintaining an erection
Fatigue
Mood changes and irritability
Depression
A loss of muscle mass

“Low testosterone in any man needs addressed,” said Dr. Samadi. “Men experiencing symptoms of low testosterone should contact their primary care physician as soon as possible to get tested and then treated for it. Doing so helps men avoid many of the health issues associated with this common condition.”
Varicocele

Varicoceles are veins that become enlarged inside the scrotum of men – comparable to developing a varicose vein in a leg. Some men with a varicocele may have issues with fertility as up to 40% of men with infertility have varicoceles. Occasionally, a man with varicoceles will notice a change in the size of their testicles; one testicle may be smaller than the other or both have shrunk.

Dr. Samadi added, “The treatment for varicoceles is usually surgery. After surgery is performed, in most cases the testicles return to their normal size.”

Congenital disorders
Sometimes a baby boy may be born with a congenital disorder that can cause testicles to be small. Klinefelter Syndrome is one such disorder.
Klinefelter syndrome is the result of one extra X chromosome (written as XXY) in baby boys and is estimated to occur in about 1 out of every 500-1,000 newborn males. Exact causes of it are not known but the error producing the extra chromosome happens at random and is not hereditary. The only suggested increased risk is that it occurs slightly higher in women who have pregnancies after age 35.

Some physical symptoms males with Klinefelter Syndrome include the following:
Slower in developing motor skills, coordination, speed, and muscle strength
Fatter around the belly
Clumsier
Smaller testes and penis
Breast growth (affects about one-third of teens)
Less facial and body hair
Reduced muscle tone
Narrower shoulders and wider hips

“While there is no cure for Klinefelter Syndrome, the symptoms can be treated successfully helping to minimize the impact of the condition,” explained Dr. Samadi.

About half of all males with Klinefelter Syndrome have low testosterone levels which can be treated by taking supplemental testosterone. Working closely with an endocrinologist, a doctor who specializes in hormones and will closely follow a man’s use of testosterone therapy, is the best way to treat this condition.

Testicular atrophy
Atrophy means to shrivel or waste away. In regards to testicular atrophy, the testicles have become smaller. Sometimes a surgery to repair an inguinal hernia can be a cause or men who’ve had repeated inguinal hernia repairs have a higher risk of testicular atrophy. Some other causes include aging, sexually transmitted diseases, mumps, and cirrhosis due to alcohol consumption.

Depending on the cause of testicular atrophy will determine the treatment. Any man with concerns of testicular atrophy for an unknown reason should seek the advice of his doctor.

“The main message for all men with concerns of testicular size is to ask their doctor about it. Likely, there is no problem but why worry unnecessarily,” advised Dr. Samadi. “Ask and if it’s treatable do so. If nothing wrong is found remember all men come in different sizes so whether large or small, as long as it works, that’s all that matters”

David B. Samadi, MD, Urologic Oncology Expert and Robotic Surgeon located at 485 Madison Avenue on the 21st floor, New York, NY – 212-365-5000. Follow Dr. Samadi at www.samadimd.com, www.prostatecancer911.com, and www.roboticoncology.com.

Dr. David Samadi
Robotic Oncology
+1 212-365-5000
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Help Your Diabetes (HYD) Announces Upcoming Grand Openings Of Their 18th, 19th and 20th Diabetes Reversal Clinics

The World’s #1 Diabetes Reversal Program

HYD's Clinic Rollout Is Continuing At A Rapid Pace

DALLAS, TEXAS, USA, November 27, 2019 /EINPresswire.com/ — Help Your Diabetes (HYD) has almost completed construction of 3 new clinics, located in Miami, Minneapolis and Las Vegas.

HYD will hold off the Grand Openings of these clinics until after January 1. This will bring the total to 20 HYD clinics, with 9 more clinics already in the process of construction.

HYD is the only company in the world that has Type 2 Diabetes Reversal clinics and they are going to be launching their Online Portal soon, which will allow any diabetic in the US the ability to sign up, even if they don't live close to one of their clinics.

"Once these 3 clinics open in January 2020, it will be our 19th clinic we've opened in the past 16 months, which is very rapid growth. There is such a huge need for our services that we are dedicated to opening clinics as fast as possible and with our online portal launching soon, every diabetic in the US will have access to our services," says Dr. J. Murray Hockings, HYD's Founder and CEO.

For more information on HYD and their current locations, please visit www.HelpYourDiabetes.com

Dr. J. Murray Hockings
Help Your Diabetes
email us here
+1 800-321-9054


Source: EIN Presswire

Dr. Mark Fleckner Explains The Difference Between An Optometrist And Ophthalmologist

Dr. Mark R. Fleckner, MD

GARDEN CITY, NEW YORK, UNITED STATES, November 27, 2019 /EINPresswire.com/ — Dr. Mark Fleckner is a board-certified New York ophthalmologist. Mark R. Fleckner MD’s areas of expertise include treating diseases affecting the retina.

Dr. Mark Fleckner’s practice strives to ensure patients are comfortable and well-informed about their treatments. This includes advising patients about which eye expert to see for which eye problem.

Accurately choosing an eye care provider is a significant health care decision. One, we often undervalue.

Some people do not know the difference between an optometrist and an ophthalmologist. Dr. Mark Fleckner wants to clear up the confusion to help people find the right treatment for their eyes.

You need to put your trust in your eye care professional. It is how you can safeguard your valuable sense of sight and maintain a lifetime of good vision.

But first, you need to know what type of eye doctor to visit when eye issues occur.

“There is a distinct difference between the two eye care professionals. Optometrists offer medical treatment for common eye problems. However, ophthalmologists treat certain eye disorders. Particularly if it involves specialty care or surgery,” says Mark R. Fleckner, MD.

Common eye problems optometrists handle include dry eyes and eye infections.

Ophthalmologists like Dr. Mark Fleckner, help patients with certain eye diseases. For example, diabetic retinopathy and macular degeneration.

Furthermore, each of these eye experts receives a different education for their specialties.

– An optometrist is an eye doctor who has earned the Doctor of Optometry (OD) degree.

– Specialties: An optometrist examines eyes for both vision and health problems. He or she corrects refractive errors by prescribing eyeglasses and contact lenses.

– An ophthalmologist is a medical doctor and a specialist in ophthalmology. Ophthalmologists generally complete four years of college and four years of medical school.

Ophthalmologists need to complete a one-year internship. All have to finish at least three years of hospital-based residency in ophthalmology.

– Specialties: An ophthalmologist performs eye exams, diagnoses, and treats certain eye diseases. He or she can prescribe medications and perform eye surgery.

Another way to look at it is to extend the analogy with dentistry. The education of an optometrist is like a general dentist. Whereas, the education and training of an ophthalmologist like an oral surgeon.

Mark R. Fleckner MD emphasizes the importance of regular eye exams. He does not want people to make their own diagnosis. He stresses how essential it is to visit an eye care professional.

It is vital to know the difference between an optometrist and an ophthalmologist. This awareness will be helpful to many people experiencing eye issues.

It is from this new understanding that people can start making better eye care decisions.

To learn more about Mark R. Fleckner MD, visit http://drmarkfleckner.com/.

Caroline Hunter
Web Presence, LLC
+1 7862338220
email us here


Source: EIN Presswire